Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study

被引:34
作者
Haakenstad, Annie [1 ]
Moses, Mark W. [2 ]
Tao, Tianchan [2 ]
Tsakalos, Golsum [2 ]
Zlavog, Bianca [2 ]
Kates, Jennifer [3 ]
Wexler, Adam [3 ]
Murray, Christopher J. L. [2 ]
Dieleman, Joseph L. [2 ]
机构
[1] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA
[2] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA
[3] Kaiser Family Fdn, San Francisco, CA USA
来源
LANCET HIV | 2019年 / 6卷 / 06期
基金
比尔及梅琳达.盖茨基金会;
关键词
SYSTEMATIC ANALYSIS; GLOBAL BURDEN; HEALTH; DISEASE;
D O I
10.1016/S2352-3018(19)30038-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20.0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spending on HIV/AIDS and estimated the potential for governments to devote additional domestic funds to HIV/AIDS. Methods We extracted 8589 datapoints reporting spending on HIV/AIDS. We used spatiotemporal Gaussian process regression to estimate a complete time series of spending by domestic sources (government, prepaid private, and out-of-pocket) and spending category (prevention, and care and treatment) from 2000 to 2016 for 137 low-income and middle-income countries (LMICs). Development assistance data for HIV/AIDS were from Financing Global Health 2018, and HIV/AIDS prevalence, incidence, and mortality were from the Global Burden of Disease study 2017. We used stochastic frontier analysis to estimate potential additional government spending on HIV/AIDS, which was conditional on the current government health budget and other finance, economic, and contextual factors associated with HIV/AIDS spending. All spending estimates were reported in 2018 US$. Findings Between 2000 and 2016, total spending on HIV/AIDS in LMICs increased from $4.0 billion (95% uncertainty interval 2.9-6.0) to $19.9 billion (15.8-26.3), spending on HIV/AIDS prevention increased from $596 million (258 million to 1.3 billion) to $3.0 billion (1.5-5.8), and spending on HIV/AIDS care and treatment increased from $1.1 billion (458.1 million to 2.2 billion) to $7.2 billion (4.3-11.8). Over this time period, the share of resources sourced from development assistance increased from 33.2% (21.3-45.0) to 46.0% (34.2-57.0). Care and treatment spending per year on antiretroviral therapy varied across countries, with an IQR of $284-2915. An additional $12.1 billion (8.4-17.5) globally could be mobilised by governments of LMICs to finance the response to HIV/AIDS. Most of these potential resources are concentrated in ten middle-income countries (Argentina, China, Colombia, India, Indonesia, Mexico, Nigeria, Russia, South Africa, and Vietnam). Interpretation Some governments could mobilise more domestic resources to fight HIV/AIDS, which could free up additional development assistance for many countries without this ability, including many low-income, high-prevalence countries. However, a large gap exists between available financing and the funding needed to achieve global HIV/AIDS goals, and sustained and coordinated effort across international and domestic development partners is required to end AIDS by 2030. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:E382 / E395
页数:14
相关论文
共 50 条
  • [11] Tobacco control funding for low-income and middle-income countries in a time of economic hardship
    Stoklosa, Michal
    Ross, Hana
    TOBACCO CONTROL, 2014, 23 (E2) : e122 - e126
  • [12] Burden of respiratory problems in low-income and middle-income countries
    Clark, Joseph
    Kochovska, Slavica
    Currow, David C.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 210 - 215
  • [13] Pathology and laboratory medicine in low-income and middle-income countries 2: Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions
    Sayed, Shahin
    Cherniak, William
    Lawler, Mark
    Tan, Soo Yong
    El Sadr, Wafaa
    Wolf, Nicholas
    Silkensen, Shannon
    Brand, Nathan
    Looi, Lai Meng
    Pai, Sanjay A.
    Wilson, Michael L.
    Milner, Danny
    Flanigan, John
    Fleming, Kenneth A.
    LANCET, 2018, 391 (10133) : 1939 - 1952
  • [14] Blood lead levels in low-income and middle-income countries: a systematic review
    Ericson, Bret
    Hu, Howard
    Nash, Emily
    Ferraro, Greg
    Sinitsky, Julia
    Taylor, Mark Patrick
    LANCET PLANETARY HEALTH, 2021, 5 (03) : E145 - E153
  • [15] Stroke systems of care in low-income and middle-income countries: challenges and opportunities
    Pandian, Jeyaraj D.
    Kalkonde, Yogeshwar
    Sebastian, Ivy Anne
    Felix, Cynthia
    Urimubenshi, Gerard
    Bosch, Jackie
    LANCET, 2020, 396 (10260) : 1443 - 1451
  • [16] Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: a meta-review
    Jarde, Alexander
    Romano, Eugenia
    Afaq, Saima
    Elsony, Asma
    Lin, Yan
    Huque, Rumana
    Elsey, Helen
    Siddiqi, Kamran
    Stubbs, B.
    Siddiqi, Najma
    BMJ OPEN, 2022, 12 (09):
  • [17] Gestational weight gain in low-income and middle-income countries: a modelling analysis using nationally representative data
    Wang, Dongqing
    Wang, Molin
    Darling, Anne Marie
    Perumal, Nandita
    Liu, Enju
    Danaei, Goodarz
    Fawzi, Wafaie W.
    BMJ GLOBAL HEALTH, 2020, 5 (11):
  • [18] Impacts of population growth and economic development on food security in low-income and middle-income countries
    Miladinov, Goran
    FRONTIERS IN HUMAN DYNAMICS, 2023, 5
  • [19] How to reduce adolescent smoking in low-income and middle-income countries
    Thomas, David P.
    Hefler, Marita
    LANCET GLOBAL HEALTH, 2016, 4 (11): : E762 - E763
  • [20] Neurosurgical Care: Availability and Access in Low-Income and Middle-Income Countries
    Punchak, Maria
    Mukhopadhyay, Swagoto
    Sachdev, Sonal
    Hung, Ya-Ching
    Peeters, Sophie
    Rattani, Abbas
    Dewan, Michael
    Johnson, Walter D.
    Park, Kee B.
    WORLD NEUROSURGERY, 2018, 112 : E240 - E254